Organon & Co | OGN - Fremdkapital





Fremdkapital Veränderung Datum
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Gilead Sciences USD 22.14B 5M 2025-09
Glaxosmithkline GBP 20.02B 4.72B 2025-09
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 24.24B 174M 2025-09
Organigram Holdings CAD 76.4M 23.6M 2025-09
Organon & Co USD 8.78B 117M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 36.68M 1.07M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tilray USD 279.22M 18.87M 2025-03